Drug recall · May 31, 2017
Norethindrone Acetate and Ethinyl Estradiol Tablets recall
Why: Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0.02 mg, 1 blister pack containing 21 tablets (NDC 0378-7280-85), packaged in 3 pouches, each contains one blister pack of 21 tablets (NDC 0378-7280-53), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India.
- Lots / codes
Lot #: 6327A006, Exp 02/18
- Quantity
- 8,605 cartons
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Nationwide in USA
- Initiated
- January 30, 2017 · Voluntary: Firm initiated
- Classified
- May 23, 2017
- Reported
- May 31, 2017
- Ended
- June 1, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ethinyl estradiol / norethindrone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.